Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Cash from Operations (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Cash from Operations for 7 consecutive years, with 8307000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 374.14% to 8307000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48914000.0 through Dec 2025, down 1841.8% year-over-year, with the annual reading at 48914000.0 for FY2025, 1841.8% down from the prior year.
  • Cash from Operations for Q4 2025 was 8307000.0 at Strata Critical Medical, up from 37297000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 8429000.0 in Q2 2024, with the low at 37297000.0 in Q3 2025.
  • Average Cash from Operations over 5 years is 8246526.32, with a median of 8307000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations tumbled 3652.82% in 2021, then soared 214.14% in 2024.
  • Over 5 years, Cash from Operations stood at 6016000.0 in 2021, then tumbled by 51.33% to 9104000.0 in 2022, then fell by 2.37% to 9320000.0 in 2023, then surged by 81.2% to 1752000.0 in 2024, then plummeted by 374.14% to 8307000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 8307000.0, 37297000.0, and 3064000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.